IGF1-LR3

IGF-LR3 (Insulin-like Growth Factor 1, Long Arg3) is a research-grade synthetic analogue of human IGF-1 modified with a 13-amino-acid N-terminal extension and an arginine substitution at position 3. These two modifications dramatically reduce affinity for IGF-binding proteins (IGFBPs), extending its functional half-life and increasing receptor availability in research settings. It is one of the most extensively studied IGF-1 analogues in cellular proliferation and anabolic signalling research.

Available in 1mg vials

RESEARCH APPLICATIONS INCLUDE:

• Cellular proliferation and myoblast differentiation studies
• IGF-1 receptor binding kinetics and downstream PI3K/Akt signalling
• Glucose uptake and insulin sensitivity pathway research
• Muscle protein synthesis and anti-catabolic mechanism investigation
• Comparative research vs native IGF-1 and other growth factor analogues
• mTOR pathway activation and cellular growth signalling studies

PRODUCT SPECIFICATIONS:

• Form: Lyophilised powder
• Purity: ≥99% 
• Storage: −20°C, protected from light and moisture
• Available strength: 1mg

⚠ For research purposes only. This product is not intended for human or veterinary use, consumption, or self-administration. Must be handled by qualified professionals in a suitable laboratory environment. Not evaluated by the MHRA or any regulatory authority for therapeutic use